ストックスクリーナーアプリを入手
3.50
1.69%
-0.06
アフターアワーズ：
3.55
0.05
+1.43%
前日終値:
$3.56
開ける：
$3.61
24時間の取引高:
1.71M
Relative Volume:
1.50
時価総額：
$254.91M
収益：
-
当期純損益:
$-95.90M
株価収益率:
-2.6515
EPS:
-1.32
ネットキャッシュフロー:
$-79.09M
1週間 パフォーマンス:
+19.86%
1か月 パフォーマンス:
+40.56%
6か月 パフォーマンス:
-49.57%
1年 パフォーマンス:
-33.84%
1日の値動き範囲:
$3.3701
$3.62
1週間の範囲:
$2.855
$3.62
52週間の値動き範囲:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
3.50 | 254.91M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | TERN Stock News - GuruFocus
What is Terns Pharmaceuticals Inc (TERN) Stock Return on Shareholders’ Capital? - Sete News
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times
Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan
An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com
Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel
Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX
Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX
A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News
TERN overperforms with a 2.86 increase in share price - uspostnews.com
Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com
An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate - Yahoo Finance
TERN’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Outperform Rating from JMP Securities - Defense World
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - ADVFN
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates - ADVFN
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock Position Raised by LPL Financial LLC - Defense World
Alliancebernstein L.P. Has $2.01 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Vanguard Group Inc. Has $21.44 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Mizuho maintains Outperform on Terns Pharma, $14 target By Investing.com - Investing.com Canada
Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback - Bloomberg.com
American Century Companies Inc. Purchases 28,330 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN
TERN Shares Experience Decline in Value - knoxdaily.com
Norges Bank Acquires New Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround - Yahoo Finance
Such Is The Power Of Terns Pharmaceuticals Inc (NASDAQ: TERN) - stocksregister.com
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance
Terns pharmaceuticals chief medical officer sells $2,365 in stock By Investing.com - Investing.com South Africa
Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia
Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st
HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World
Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks
Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa
Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com
Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
Terns Pharmaceuticals Inc (TERN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
| Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
| Quigley Jill M. | Director |
Jan 06 '25 |
Sale |
5.79 |
8,760 |
50,758 |
0 |
| Quigley Jill M. | Director |
Jan 02 '25 |
Sale |
5.72 |
6,240 |
35,702 |
8,760 |
0.47%
2.63%
大文字化:
|
ボリューム (24 時間):